Buscar
Mostrando ítems 1-10 de 177
Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis
Cytokine storm induced by the coronavirus 19 (COVID-19) profoundly activates the coagulation
cascade causing venous thromboembolism (VTE). Initial studies from Wuhan, China showed
increased incidence of VTE in patients ...
Oral dietary intake level in thrombolysed and non-thrombolysed patients after ischemic stroke
(2017-01-01)
BACKGROUND: Dysphagia can be a stroke sequelae and may impact patient prognosis. Thrombolytic therapy has been used as a treatment of choice which aims to reduce sequelae. OBJECTIVE: Assess the ability of dietary intake ...
Acute myocardial infarction mortality in Chile. Thrombolysis or angioplasty Mortalidad por infarto del miocardio en Chile. Trombolíticos o angioplastía
(2011)
During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and ...
Infarto agudo del miocardio: el factor tiempo
(Sociedad Médica de Santiago, 2008)
The Incidence of Dysphagia in Patients Receiving Cerebral Reperfusion Therapy Poststroke
(Elsevier B.V., 2014-07-01)
Background: The high prevalence of dysphagia after stroke leads to increased mortality, and cerebral reperfusion therapy has been effective in reducing neurologic deficits. The aim of this study was to investigate the ...
Thrombolytic therapy for eligible elderly patients with actite myocardial infarction - Reply
(Mosby, Inc, 2005-05-01)
Hepatic bleeding induced by streptokinase and heparin in a patient with acute myocardial infarction
(2002-12-01)
Although rare, major bleeding is the most important side effect of thrombolytic therapy in acute myocardial infarction (AMI) (Levine et al., 1995). Spontaneous hepatic bleeding in normal liver after thrombolytic administration ...
Hepatic bleeding induced by streptokinase and heparin in a patient with acute myocardial infarction
(2002-12-01)
Although rare, major bleeding is the most important side effect of thrombolytic therapy in acute myocardial infarction (AMI) (Levine et al., 1995). Spontaneous hepatic bleeding in normal liver after thrombolytic administration ...
Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction Utilidad de la terapia trombolítica con estreptokinasa a dosis baja en infarto agudo del miocardio
(2006)
Background: The optimal dose of Streptokinase in the treatment of acute myocardial infarction is not well established. Apparently, the thrombolytic efficacy would not increase with doses over 750.000 units. Aim: To compare ...
Trombolisis endovenosa post reversión de acenocumarol con complejo de protrombina. Caso clínico
(Sociedad Médica de Santiago, 2019)
We report an 89-year-old male under oral anticoagulant therapy with a therapeutic international normalized ratio, presenting at the emergency room with right side hemiparesis and aphasia. Neuroimaging was compatible with ...